Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 SEK | -1.49% | -9.20% | -37.30% |
Apr. 26 | Q-Linea AB Receives FDA 510(k) Clearance for the ASTar® System | CI |
Mar. 13 | Q-linea AB Presents Strong ASTar Results At AMCLI | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-37.30% | 24.86M | |
-15.43% | 18.51B | |
-40.81% | 2.85B | |
+19.34% | 1.95B | |
+2.22% | 1.72B | |
+28.27% | 1.26B | |
-9.56% | 1.02B | |
-16.29% | 950M | |
+0.07% | 777M | |
-22.49% | 643M |
- Stock Market
- Equities
- QLINEA Stock
- News Q-linea AB
- Transcript : Q-linea AB, Q4 2023 Earnings Call, Feb 27, 2024